Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mirtazapine in Alzheimer-associated Weight Loss: a Retrospective Phase IV Study

NCT01505504 is registered in ClinicalTrials.gov with Brugmann University Hospital as lead sponsor.

NCT NCT01505504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01505504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mirtazapine in Alzheimer-associated Weight Loss: a Retrospective Phase IV Study
Lead sponsor
Brugmann University Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2004
Completion date
December 31, 2011
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, dementia, mixed dementia, weight loss